LDS

N/A

Report date: 2025/11/14 20:00:34
NME

Base Information

Drug NameLDS
Drug Alias NameLD-04185
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily A member 1 inhibitors
TargetsTransient receptor potential cation channel subfamily A member 1
Therapy Area/IndicationsFibromyalgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Lidao Medical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Lidao Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsFibromyalgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A